Cresco Labs Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Cresco Labs wird ein Gewinn- und Umsatzwachstum von 59.6% bzw. 1.9% pro Jahr prognostiziert, während der Gewinn pro Aktie um 67.6% pro Jahr wachsen soll.

Wichtige Informationen

59.6%

Wachstumsrate der Gewinne

67.6%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum	23.9%
Wachstumsrate der Einnahmen	1.9%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Good
Zuletzt aktualisiert	22 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

OTCPK:CRLB.F - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	733	-26	52	70	3
12/31/2025	726	-21	43	76	8
12/31/2024	724	-68	97	130	8
9/30/2024	726	-67	75	100	N/A
6/30/2024	735	-172	59	91	N/A
3/31/2024	747	-155	48	92	N/A
12/31/2023	756	-176	1	59	N/A
9/30/2023	767	-339	-1	65	N/A
6/30/2023	786	-234	-23	50	N/A
3/31/2023	806	-211	-44	25	N/A
12/31/2022	825	-212	-67	19	N/A
9/30/2022	842	-65	-38	53	N/A
6/30/2022	848	-326	-62	34	N/A
3/31/2022	841	-318	-114	-2	N/A
12/31/2021	806	-320	-83	14	N/A
9/30/2021	750	-360	-99	-3	N/A
6/30/2021	687	-73	-74	20	N/A
3/31/2021	573	-105	-25	43	N/A
12/31/2020	463	-102	-97	-8	N/A
9/30/2020	345	-76	-149	-34	N/A
6/30/2020	231	-98	-186	-70	N/A
3/31/2020	168	-64	-185	-57	N/A
12/31/2019	124	-43	-121	-25	N/A
9/30/2019	101	-20	-94	-29	N/A
6/30/2019	78	-14	-67	-20	N/A
3/31/2019	57	-12	-53	-16	N/A
12/31/2018	41	-2	-40	-10	N/A
9/30/2018	28	0	-26	-4	N/A
6/30/2018	19	1	N/A	-7	N/A
3/31/2018	13	1	N/A	-6	N/A
12/31/2017	10	-3	N/A	-5	N/A
12/31/2016	3	-8	N/A	-11	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CRLB.F wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: CRLB.F wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: CRLB.F wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: CRLB.FDie Einnahmen des Unternehmens (1.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).

Hohe Wachstumseinnahmen: CRLB.FDie Einnahmen des Unternehmens (1.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CRLB.F in 3 Jahren voraussichtlich hoch sein wird

Cresco Labs Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023

Cresco Labs Inc. Provides Earnings Guidance for the Year 2021

Recent updates

Cresco Labs Inc. to Report Q3, 2024 Results on Nov 08, 2024

Cresco Labs Inc. Announces Resignation of Tarik Brooks as Board of Directors

Cresco Labs Inc. Announces CFO Changes

Cresco Labs Inc. to Report Q2, 2024 Results on Aug 08, 2024

Cresco Labs Inc. (CNSX:CL) acquired Two medical dispensaries in Pennsylvania of Keystone Integrated Care, LLC for $9.8 million.

Cresco Labs Inc. to Report Q1, 2024 Results on May 15, 2024

Cresco Labs Inc., Annual General Meeting, Jun 10, 2024

Cresco Labs Inc. to Report Q4, 2023 Results on Mar 13, 2024

Cresco Labs Inc. Promotes Greg Butler to the Position of President

Cresco Labs Inc. to Report Q3, 2023 Results on Nov 15, 2023

Cresco Labs Inc. completed the acquisition of Sole Licensed Arizona Operation of Cresco Labs Inc.

Cresco Labs Inc. Provides Revenue Guidance for the Second Half of 2023

Cresco Labs Inc. to Report Q2, 2023 Results on Aug 16, 2023

Cresco Labs Inc. to Report Q1, 2023 Results on May 24, 2023

Combs Enterprises signed a definitive agreements to acquire Certain New York, Illinois, and Massachusetts assets of Cresco Labs Inc. and Columbia Care Inc. for approximately $190 million.

Cresco Labs Inc. to Report Q3, 2022 Results on Nov 15, 2022

Cresco Labs Inc. Announces Resignation of Sidney Dillard from the Board of Director

Aventine Property Group, Inc. acquired Cresco Labs Facility in Brookville, PA for $45 million

Cresco Labs Inc. to Report Q2, 2022 Results on Aug 17, 2022

Cresco Labs Inc. to Report Q1, 2022 Results on May 18, 2022

Cresco Labs Inc., Annual General Meeting, Jun 30, 2022

Cresco Labs Inc. Launches Floracal Farms Brand to Illinois

Cresco Labs Announces Launch of Khalifa Kush Products at Cookies Dispensaries Throughout California

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Laurel Harvest Labs, LLC for $80 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Bay, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Bay, LLC for $90 million.

Cresco Labs Inc. (CNSX:CL) completed the acquisition of Cultivate Holdings, LLC.

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Blair Wellness, LLC.

Cresco Labs Inc. Provides Earnings Guidance for the Year 2021

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire Cultivate Holdings, LLC for $158 million.

IM Cannabis Corp. (CNSX:IMCC) completed the acquisition of Trichome Financial Corp. (CNSX:TFC) from Cresco Labs Inc., Opaskawayak Cree Nation and others.

Cresco Labs Inc. to Report Q4, 2020 Results on Mar 25, 2021

Cresco Labs Inc. (CNSX:CL) acquired Four dispensaries of Verdant Creations.

Cresco Labs Signs Exclusive Distribution Agreement with California Cannabis Producer, Emerald Family Farms

Cresco Labs Appoints Ty Gent as the New Chief Operating Officer

Cresco Labs Expands High Supply Brand Portfolio to Include 1.0 g and 0.5 mg Live Cartridges Available in California and Illinois

Cresco Labs Inc. has completed a Follow-on Equity Offering in the amount of CAD 158.047776 million.

Cresco Labs Announces Executive Changes

Cresco Labs Inc. (CNSX:CL) entered into a definitive agreement to acquire all of the issued and outstanding shares of Bluma Wellness Inc. (CNSX:BWEL.U) for approximately $180 million.

Cresco Labs Debuts Deliciously DosedTM Chocolates from its Mindy's Chef Led Artisanal Edibles Brand for the Illinois Recreational Cannabis Market

Cresco Labs Launches Eighth Cannabis Brand, Wonder Wellness Co

Cresco Labs Launches 1.0 g Liquid Live Resin Vape Offering in Illinois and California

Cresco Labs Launches Remedi Cannabis Brand into New York

Cresco Labs Inc. to Report Q3, 2020 Results on Nov 18, 2020

Cresco Labs Bolsters Leadership Team with Three Senior Promotions

Innovative Industrial Properties, Inc. (NYSE:IIPR) completed the acquisition of two properties in Ohio and Michigan from Cresco Labs Inc. (CNSX:CL).

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken